Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide

Béatrice Leveugle; Wanhong Ding; Laurence Fenart; Marie-Pierre Dehouck; Andrew Scanameo; Roméo Cecchelli; Howard Fillit

Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide

Béatrice Leveugle Wanhong Ding Laurence Fenart ¹ Marie-Pierre Dehouck ¹ Andrew Scanameo Roméo Cecchelli ¹ Howard Fillit

1 LBHE - Laboratoire de Physiopathologie de la Barrière Hémato-Encéphalique

Abstract : We have previously demonstrated that full-length heparin stimulates the synthesis and secretion of β-amyloidprecursor protein (APP) through an amyloidogenic pathway in neuroblastoma cells. In the present study, heparin was chemically depolymerized, and the effect of low-molecular-weight (LMW) hepanin on APP secretion was investigated. In contrast to full-length hepar, LMW heparin had no significant effect on APP secretion. However, LMW heparin fragments, especially heparin disaccharides, were able to inhibit efficiently the stimulatory effect of heparin on APP secretion. LMW heparin derivatives also inhibit the binding of heparin to the β-amyloid peptide (1-28). Using an in vitro model, we further demonstrated the passage of LMW heparin derivatives through the blood-brain barrier. This study suggests that LMW heparin derivatives or analogues may be effective as therapeutic agents to prevent or slow the process of amyloidogenesis in Alzheimer's disease.

Keywords : Heparan sulfate Alzheimer's disease Proteoglycans Glycosaminoglycans Therapy

Type de document :

Article dans une revue

Journal of Neurochemistry, Wiley, 1998, 70 (2), p. 736-744

Domaine :

Sciences du Vivant [q-bio] / Biochimie, Biologie Moléculaire

Liste complète des métadonnées

https://hal-univ-artois.archives-ouvertes.fr/hal-00524713
Contributeur : Wilfried Déplanques <>
Soumis le : vendredi 8 octobre 2010 - 16:01:28
Dernière modification le : vendredi 8 octobre 2010 - 16:01:28

Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide

Identifiants

Collections

Citation

Exporter

Métriques

85

Contact

Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide

Identifiants

Collections

Citation

Exporter

Partager

Métriques

85

Contact